Robert S. Fenning

faculty photo
Assistant Professor of Clinical Medicine (Cardiovascular Medicine)
Member, Penn Cardiovascular Institute and the Institute for Translational Medicine and Therapeutics
Department: Medicine

Contact information
Penn Presbyterian Medical Center
51 N. 39th Street
Heart and Vascular Pavilion
4th Floor
Philadelphia, PA 19104
Education:
BA (Biology)
Cornell University, College of Arts and Sciences, Ithaca, NY, 2004.
MD (Medicine)
University of Pennsylvania School of Medicine, Philadelphia, PA, 2008.
Post-Graduate Training
Intern, Internal Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, 2008-2008.
Resident, Internal Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, 2009-2011.
General Cardiovascular Disease Fellowship, Hospital of the University of Pennsylvania, Philadelphia, PA, 2011-2014.
Interventional Cardiology Fellowship, Hospital of the University of Pennsylvania, Philadelphia, PA, 2014-2015.
Fellowship Training in Peripheral Interventions, Terrebond General Medical Center, Cardiovascular Institute of the South, Houma Louisiana. Mentor Dr. Craig Walker., 2015-2015.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Saybolt MD, Lilly SM, Patel D, Hamamdzic D, Llano R, Fenning RS, Madden S, Wilensky RL: The vulnerable artery: early and rapid deposition of lipid in coronary arteries is associated with subsequent development of thin-cap fibroatheromas. EuroIntervention 11(14): e1612-8, April 8 2016.

Fenning RS, Burgert ME, Hamamdzic D, Peyster EG, Mohler ER 3rd, Kangovi S, Jucker BM, Lenhard S, Li J, Hoffman BE, Macphee CH, Wilensky RL: Atherosclerosis differs between vascular sites by plaque severity, gene expression, and the role of lipoprotein-associated phospholipase A2. J Am Heart Assoc 4(2), February 2015 Notes: e001477.

Fenning RS and Wilensky RL: New insights into the vulnerable plaque from imaging studies. Curr Atheroscler Rep. 16(3): 397-397, March 2014.

Merschen RJ, Fenning RS, Wascho R, and Goldberg SM: Saphenous vein graft to left circumflex stenting with significant distal and proximal disease: a complex case utilizing a covered stent. Cath Lab Digest 1(22): 1-3, January 2014.

Patel D, Hamamdzic D, Llano R, Patel D, Cheng L, Fenning RS, Bannan K, Wilensky RL: Subsequent development of fibroatheromas with inflamed fibrous caps can be predicted by intracoronary near infrared spectroscopy. Thromb Vasc Biol 33(2): 347-353, February 2013 Notes: Published.

Patel D, Hamamdzic D, Llano R, Patel D, Cheng L, Fenning RS, Bannan K, and Wilensky RL: Subsequent development of fibroatheromas with inflamed fibrous caps can be predicted by intracoronary near infrared spectroscopy. Arterioscler Thromb Vasc Biol 33(2): 347-53, February 2013.

Fenning RS, Peyster EG, Kangovi S, Hamamdzic D, Burgert ME, Macphee CH, and Wilensky RL: Atherosclerotic plaque development differs between vascular sites with unique phenotypic and gene expression profiles. Mid-Atlantic Annual Capital Cardiology Symposium, Washington DC November 2012 Notes: Poster presentation.

Qamar A, Fenning RS, Qasim AN, Mehta NN, Reilly MP, Rader DJ. : Plasma Fibroblast growth factor-21 levels are positively associated with metabolic syndrome, insulin resistance and systemic inflammation. American Heart Association Meeting, Los Angeles CA November 2012 Notes: Poster presentation.

Heuer GG, Fenning RS, Brown M, Kilbaugh T, Guzman MA, Judkins AR, Rorke-Adams L, Sutton LN, Storm PB: Pulmonary edema and cardiac dysfunction after resection of a fourth ventricle tumor in a toddler: case report. Childs Nerv Syst. 27(11): 2005-9, November 2011.

Fenning RS, Qamar A, Millar J, DerOhannessian S, Wolfe M, Rader DJ: PPAR-alpha and PPAR-gamma agonists modulate Fibroblast Growth Factor-21 levels in patients with the metabolic syndrome and dyslipidemia. Arteriosclerosis, Thrombosis, and Vascular Biology Meeting, Chicago, IL April 2011 Notes: Poster Presentation.

back to top
Last updated: 01/26/2024
The Trustees of the University of Pennsylvania